These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17380440)

  • 1. Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay.
    Amano M; Suzuki M; Andoh S; Monzen H; Terai K; Williams B; Song CW; Mayo KH; Hasegawa T; Dings RP; Griffin RJ
    Int J Clin Oncol; 2007 Feb; 12(1):42-7. PubMed ID: 17380440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells.
    Dings RP; Williams BW; Song CW; Griffioen AW; Mayo KH; Griffin RJ
    Int J Cancer; 2005 Jun; 115(2):312-9. PubMed ID: 15688384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin.
    Dings RP; Yokoyama Y; Ramakrishnan S; Griffioen AW; Mayo KH
    Cancer Res; 2003 Jan; 63(2):382-5. PubMed ID: 12543791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbeam radiation therapy alters vascular architecture and tumor oxygenation and is enhanced by a galectin-1 targeted anti-angiogenic peptide.
    Griffin RJ; Koonce NA; Dings RP; Siegel E; Moros EG; Bräuer-Krisch E; Corry PM
    Radiat Res; 2012 Jun; 177(6):804-12. PubMed ID: 22607585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-κB signaling pathways.
    Ma K; Wang C; Geng Q; Fan Y; Ning J; Yang H; Dong X; Dong D; Guo Y; Wei X; Li E; Wu Y
    Oncol Rep; 2016 Jun; 35(6):3505-13. PubMed ID: 27035232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.
    Dings RP; Loren M; Heun H; McNiel E; Griffioen AW; Mayo KH; Griffin RJ
    Clin Cancer Res; 2007 Jun; 13(11):3395-402. PubMed ID: 17545548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronomic small molecule inhibitor of Bcl-2 (TW-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiation.
    Zeitlin BD; Spalding AC; Campos MS; Ashimori N; Dong Z; Wang S; Lawrence TS; Nör JE
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):879-87. PubMed ID: 20675079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasculatures in tumors growing from preirradiated tissues: formed by vasculogenesis and resistant to radiation and antiangiogenic therapy.
    Chen FH; Chiang CS; Wang CC; Fu SY; Tsai CS; Jung SM; Wen CJ; Lee CC; Hong JH
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1512-21. PubMed ID: 21621344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenesis and anti-tumor activity of recombinant anginex.
    Brandwijk RJ; Dings RP; van der Linden E; Mayo KH; Thijssen VL; Griffioen AW
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1073-8. PubMed ID: 16970922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor activity of the novel angiogenesis inhibitor anginex.
    Dings RP; van der Schaft DW; Hargittai B; Haseman J; Griffioen AW; Mayo KH
    Cancer Lett; 2003 May; 194(1):55-66. PubMed ID: 12706859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy.
    Huber PE; Bischof M; Jenne J; Heiland S; Peschke P; Saffrich R; Gröne HJ; Debus J; Lipson KE; Abdollahi A
    Cancer Res; 2005 May; 65(9):3643-55. PubMed ID: 15867359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models.
    van der Schaft DW; Dings RP; de Lussanet QG; van Eijk LI; Nap AW; Beets-Tan RG; Bouma-Ter Steege JC; Wagstaff J; Mayo KH; Griffioen AW
    FASEB J; 2002 Dec; 16(14):1991-3. PubMed ID: 12397082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent.
    Wang JB; Wang MD; Li EX; Dong DF
    Peptides; 2012 Dec; 38(2):457-62. PubMed ID: 22985857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of anginex gene therapy and radiation decelerates the growth and pulmonary metastasis of human osteosarcoma xenografts.
    Zhao K; Yang SY; Geng J; Gong X; Gong W; Shen L; Ning B
    Cancer Med; 2018 Jun; 7(6):2518-2529. PubMed ID: 29659181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer.
    Cao C; Albert JM; Geng L; Ivy PS; Sandler A; Johnson DH; Lu B
    Cancer Res; 2006 Dec; 66(23):11409-15. PubMed ID: 17145887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
    Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor effect of radiation response by combined treatment with angiogenesis inhibitor, TNP-470, in oral squamous cell carcinoma.
    Shintani S; Li C; Mihara M; Klosek SK; Terakado N; Hino S; Hamakawa H
    Oral Oncol; 2006 Jan; 42(1):66-72. PubMed ID: 16140034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models.
    Koonce NA; Griffin RJ; Dings RPM
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa).
    Huang SM; Li J; Armstrong EA; Harari PM
    Cancer Res; 2002 Aug; 62(15):4300-6. PubMed ID: 12154033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.